Cardiology perspective of Mitral valve disease – The potential role of Percutaneous Treatment (pp. 361-390)
Authors: (A. Krishnaswamy, and Brian Griffin)
Abstract: The characteristic shape of the mitral valve (MV) was first described by Andre Vesalius in 1543. Our understanding of the valve has grown considerably since that time with regard to normal valve function and the anatomic and histopathologic mechanisms of disease. Furthermore, the imaging modalities for diagnosis and percutaneous strategies for treatment are continually evolving, and represent a paradigm shift in our approach to mitral valve disease. In this chapter, we will provide an overview of normal mitral valve anatomy, the etiology and mechanisms of mitral stenosis and mitral regurgitation, as well as the available medical and percutaneous options for treatment.